Current and future paradigms in the management of Esophageal Cancer
In data released by GLOBOCAN 2020, stomach Cancer is the 5th biggest cancer in the world, with esophageal Cancer...
Pembrolizumab
FDA Approves Pembrolizumab, the First Anti-PD1 Therapy for HER2 Positive Gastric Cancer
The Food and Drug Administration grants accelerated approval to Merck’s Keytruda (pembrolizumab), the checkpoint inhibitor drug for HER2-positive gastric...